Christoph Renner

Zuerich (kreis 7) / Hirslanden, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Tuning Competing Electronic Phases in Monolayer VSe2 via Interface Hybridization.

Tuning Competing Electronic Phases in Monolayer VSe2 via Interface Hybridization.

Journal: ACS nano

Published: March 03, 2026

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma.

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma.

Journal: Bone marrow transplantation

Published: January 15, 2026

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.

Journal: Swiss medical weekly

Published: October 23, 2025

Doping Tunable CDW Phase Transition in Bulk 1T-ZrSe2.

Doping Tunable CDW Phase Transition in Bulk 1T-ZrSe2.

Journal: Nano letters

Published: January 15, 2025

Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition.

Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition.

Journal: HemaSphere

Published: January 03, 2025

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Journal: Swiss medical weekly

Published: October 28, 2024

IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity.

IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity.

Journal: Cancers

Published: July 12, 2024

Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology.

Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology.

Journal: Acta dermato-venereologica

Published: July 08, 2024

Twist-Angle-Dependent Electronic Properties of Exfoliated Single Layer MoS2 on Au(111).

Twist-Angle-Dependent Electronic Properties of Exfoliated Single Layer MoS2 on Au(111).

Journal: Nano letters

Published: October 16, 2023

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.

Journal: Hematological oncology

Published: August 28, 2023

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).

Journal: EClinicalMedicine

Published: May 18, 2023

Tunable biaxial strain device for low-dimensional materials.

Tunable biaxial strain device for low-dimensional materials.

Journal: The Review of scientific instruments

Published: February 01, 2023

Showing 1-12 of 93

Last Updated: 09/26/2026